SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-21-001079
Filing Date
2021-02-25
Accepted
2021-02-25 16:30:09
Documents
3
Period of Report
2021-02-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K curr_8k.htm 8-K 19570
2 CONSENT AND WAIVER AGREEMENT curr_ex101.htm EX-10.1 14944
3 PRESS RELEASE curr_ex991.htm EX-99.1 12075
  Complete submission text file 0001477932-21-001079.txt   47807
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55908 | Film No.: 21680807
SIC: 2834 Pharmaceutical Preparations